Barely three years since its coronavirus vaccine helped stem the pandemic, Pfizer’s stock has lost 50 percent of its value ...

The activist investment firm Starboard Value has launched a proxy fight again Pfizer, questioning the company’s management ...

With valuations growing across the stock market and the biopharma sector, it's only natural for value-sensitive investors to ...

Pfizer PFE announced that the FDA has approved its subcutaneously administered drug marstacimab for treating certain ...

This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily ...

All the companies have skin in the game for clotting/bleeding disorders. The BMS-Pfizer Alliance market Factor Xa blood ...

Looking at a slightly longer term, the performance of PFE stock with respect to the index has been quite volatile in recent ...

Former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio said they will not be involved with activist investor Starboard Value, ...

The corporate clash between Pfizer and Starboard Value heated up on Thursday when the activist investment firm pressed the ...

Story of activist fund Starboard Value taking $1B position in Pfizer is grabbing headlines the last few days. Read why I ...

Pfizer’s situation with activist investor Starboard Value is already getting messy. | After initially supporting a meeting ...

Activist investor Starboard Value claims the pharma giant’s former CEO and CFO were “threatened” into backing current ...